PD-1/L1 inhibitor combined with chemotherapy

DRUG3 trials

Sponsors

Hunan Province Tumor Hospital, Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions

Locally Advanced, Recurrent or Metastatic MalignanciesNon Small Cell Lung CancerNon-small Cell Lung Cancer

Phase 2

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

RecruitingNCT07022002

Shenyang Sunshine Pharmaceutical Co., LTD.Locally Advanced, Recurrent or Metastatic Malignancies

Start: 2025-07-30End: 2027-12-12Target: 340Updated: 2025-08-03

Phase 3

Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer

Not yet recruitingNCT06828757

Hunan Province Tumor HospitalNon Small Cell Lung Cancer

Start: 2025-05-01End: 2027-04-30Target: 94Updated: 2025-02-19

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

Not yet recruitingNCT07477808

Hunan Province Tumor HospitalNon-small Cell Lung Cancer

Start: 2026-04-01End: 2029-04-01Target: 116Updated: 2026-03-23